XML 20 R10.htm IDEA: XBRL DOCUMENT
v3.26.1

Equity Method Investment | 6 Months Ended
--- | ---
Jun. 30, 2026
Equity Method Investments and Joint Ventures [Abstract] |
Equity Method Investment | Equity Method Investment In 2025, the Company invested in a start-up to develop and commercialize artificial intelligence technologies for consumer applications. As the Company exerts significant influence but is not deemed to control the start-up, it accounted for its investment as an equity method investment that was not material as of June 30, 2026 and December 31, 2025. In conjunction with its investment, the Company entered into a $4,000 revolving credit facility with the start-up. Loans under the revolving credit facility bear interest at daily simple Secured Overnight Financing Rate (“SOFR”) plus 5.5%, accruing daily and compounding quarterly into the principal amount. On April 30, 2026, the start-up drew in full upon the facility, with a principal balance of $4,000 issued at par (the “Member Loan”) with a maturity date on April 30, 2030. During the three months ended June 30, 2026, the Company recognized a provision on credit loss related to the Member Loan of $800. As of June 30, 2026, the Member Loan balance, net of allowances, was $3,200 which was recorded as “Equity method investment and loan receivable, net” on the condensed consolidated balance sheets.

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group. + References Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef -Topic 740 -SubTopic 323 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478156/740-323-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Topic 323 -Publisher FASB -URI https://asc.fasb.org/323/tableOfContent + Details
Name: | us-gaap_EquityMethodInvestmentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration